Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 3Completed 3Terminated 1No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Hepatitis B, Chronic 1Hepatitis B 1Burkitt Lymphoma 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Tenofovir × Clear all
NCT04392700 2020-05-19

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Sun Yat-sen University

Phase 3 Unknown
706 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04160897 2019-11-13

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Ruijin Hospital

Unknown
4,000 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02308319 2014-12-04

POWER

Samsung Medical Center

Phase 4 Unknown
124 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡